Compounds

Bellenamine(D-b-lysylmethanediamine)

Bellenamine(D-b-lysylmethanediamine)_1

Producing organism:

Streptomyces nashvillensis MD743-GF4

Activity:

Antibacterial

Clinical use:

-

Class no:

8 Reference(s)

Search PubMed »

Please scroll horizontally.

Title	Author	Journal	Year	Volume	Page
D-β-Lysylmethanediamine, a new biogenetic amine produced by a Streptomyces.	Y. Ikeda; S. Kondo; D. Ikeda; K. Yokose; H. Furutani; T. Ikeda; M. Hamada; M. Ishizuka; T. Takeuchi; H. Umezawa	J. Antibiotics	1986	39	476-478
Total syntheses of bellenamine and its isomers.	Y. Ikeda; D. Ikeda; S. Kondo	J. Antibiotics	1992	45	1677-1680
Production of bellenamine and new metabolites in a synthetic medium.	Y. Ikeda; S. Gomi; M. Hamada; S. Kondo; T. Takeuchi	J. Antibiotics	1992	45	1763-1766
Biosynthesis of bellenamine by Streptomyces nashvillensis using stable isotope labeled compounds.	Y. Ikeda; H. Naganawa; S. Kondo; T. Takeuchi	J. Antibiotics	1992	45	1919-1924
Preparation of 13C and 15N labeled bellenamine and its degradation products.	Y. Ikeda; H. Naganawa; S. Kondo; T. Takeuchi	J. Antibiotics	1992	45	1925-1929
Tetrahydro-4(1H)-pyrimidinone ring formation of bellenamine, a biogenic amine, with carbonyl compounds.	Y. Ikeda; S. Gomi; H. Naganawa; D. Ikeda; S. Kondo	Bull. Chem. Soc. Jpn.	1994	67	1904-1911
New bellenamine homologs inhibiting human immunodeficiency virus type 1 infectivity.	S. Kondo; Y. Ikeda; T. Takeuchi; R. Shinei; S. Gomi; S. Shibahara; Y. Haraguchi; R. Ikeda; H. Hoshino	J. Antibiotics	1996	49	113-114
Inhibition of human immunodeficiency virus type 1 infectivity by a new amine bellenamine.	R. Ikeda; Y. Haraguchi; Y. Ikeda; S. Kondo; T. Takeuchi; H. Hoshino	Antiviral Research	1996	29	163-173